|
Market Closed -
Nasdaq
16:00:00 2026-09-08 EDT
|
After hours 20:00:00 | |||
| 8.290 USD | +2.60% |
|
8.210 | -0.97% |
| 08-10 | ImmunityBio, Inc. Announces Appointment of Dr. Jim Yong Kim as Vice Chairman | CI |
| 08-04 | ImmunityBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 8.79B 7.55B 7.11B 6.49B 12.1B 833B 12.17B 84.21B 32.58B 426B 32.99B 32.27B 1,355B | P/E 2026 * |
-8.64x | P/E 2027 * | -58.2x |
|---|---|---|---|---|---|
| Enterprise Value | 8.79B 7.55B 7.11B 6.49B 12.1B 833B 12.17B 84.21B 32.58B 426B 32.99B 32.27B 1,355B | EV / Sales 2026 * |
38.9x | EV / Sales 2027 * | 19.9x |
| Free-Float |
37.83% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IBRX | Delayed | |
CBOE
| IBRX | Real-time | |
|
Tradegate
| 26CA | Real-time | |
|
Xetra
| 26CA | Delayed | |
|
Boerse Muenchen
| 26CA | Real-time | |
|
Deutsche Boerse AG
| 26CA | Delayed | |
|
Börse Stuttgart
| 26CA | Delayed |
Last Transcript : ImmunityBio, Inc.
| 1 day | -0.97% | ||
| 1 week | +5.34% | ||
| Current month | +4.28% | ||
| 1 month | +8.51% | ||
| 3 months | +15.62% | ||
| 6 months | -4.38% | ||
| Current year | +318.69% |
| 1 week | 7.88 |  | 8.37 |
| 1 month | 7.42 | | 8.76 |
| Current year | 1.98 | | 12.43 |
| 1 year | 1.95 | | 12.43 |
| 3 years | 1.25 | | 12.43 |
| 5 years | 1.21 | | 12.43 |
| 10 years | 1.21 | | 40.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 57 | 2020-09-30 |
| Chief Executive Officer | 73 | 2015-02-28 | |
David Sachs
DFI | Director of Finance/CFO | 48 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Wesley Clark
BRD | Director/Board Member | 80 | 2021-01-31 |
| Director/Board Member | 71 | 2021-02-28 | |
| Chairman | 73 | 2014-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/2/26 | Exercice | Director | 243,168 | 0.0232% | ||
| 7/1/26 | Exercice | Director | 478,434 | 0.0457% | ||
| 6/30/26 | Exercice | Director | 3,000 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.60% | +5.34% | +243.98% | +542.64% | 8.56B | |
| +2.02% | +1.26% | +41.37% | +105.18% | 67.82B | |
| -0.41% | -2.30% | +33.53% | +78.63% | 63.22B | |
| -1.11% | +2.78% | -14.86% | +375.59% | 27.58B | |
| -4.92% | -3.22% | -3.90% | -17.87% | 26.06B | |
| +0.81% | +0.93% | +31.97% | +16.39% | 25.38B | |
| +1.12% | +0.84% | +24.50% | -17.84% | 19.89B | |
| +6.04% | +7.25% | +233.25% | +383.12% | 17.4B | |
| +0.82% | 0.00% | -5.83% | +531.24% | 14.95B | |
| -2.27% | +1.37% | +53.01% | +160.83% | 14.62B | |
| Average | +0.13% | +1.06% | +63.70% | +215.79% | 28.55B | |
| Weighted average by Cap. | +0.26% | +0.44% | +43.96% | +152.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 226M 194M 183M 167M 311M 21.4B 313M 2.16B 837M 10.94B 848M 829M 34.81B | 441M 380M 357M 326M 608M 41.85B 611M 4.23B 1.64B 21.39B 1.66B 1.62B 68.07B |
| Net income | -1B -863M -812M -741M -1.38B -95.19B -1.39B -9.62B -3.72B -48.65B -3.77B -3.69B -155B | -150M -129M -122M -111M -207M -14.25B -208M -1.44B -557M -7.28B -564M -552M -23.18B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | US$8.290 | +2.60% | 7,735,941 |
| 26-09-04 | US$8.080 | -1.34% | 4,330,218 |
| 26-09-03 | US$8.190 | +3.02% | 5,271,763 |
| 26-09-02 | US$7.950 | +1.02% | 7,228,321 |
| 26-09-01 | US$7.870 | -1.01% | 6,465,675 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IBRX Stock
Select your edition
All financial news and data tailored to specific country editions
